Scarica l'app Stockscreener
26.72
1.75%
0.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$26.26
Aprire:
$26.62
Volume 24 ore:
461.41K
Relative Volume:
0.38
Capitalizzazione di mercato:
$1.77B
Reddito:
$5.79M
Utile/perdita netta:
$-199.61M
Rapporto P/E:
-8.8771
EPS:
-3.01
Flusso di cassa netto:
$-188.48M
1 W Prestazione:
-0.41%
1M Prestazione:
+4.37%
6M Prestazione:
+36.47%
1 anno Prestazione:
-5.01%
Intervallo 1D:
$26.18
$26.77
Intervallo di 1 settimana:
$25.97
$28.59
Portata 52W:
$14.40
$29.38
Celldex Therapeutics Inc Stock (CLDX) Company Profile
Nome
Celldex Therapeutics Inc
Settore
Industria
Telefono
908-200-7500
Indirizzo
53 FRONTAGE ROAD, HAMPTON
Confronta CLDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLDX
Celldex Therapeutics Inc
|
26.72 | 1.74B | 5.79M | -199.61M | -188.48M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-10-13 | Iniziato | Barclays | Underweight |
| 2025-04-28 | Iniziato | Canaccord Genuity | Buy |
| 2025-03-20 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-13 | Iniziato | UBS | Buy |
| 2024-10-07 | Iniziato | Citigroup | Buy |
| 2024-09-30 | Iniziato | Goldman | Neutral |
| 2024-09-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-18 | Iniziato | Stifel | Buy |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2023-12-20 | Iniziato | TD Cowen | Outperform |
| 2023-11-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-08-22 | Iniziato | Wells Fargo | Underweight |
| 2021-09-17 | Iniziato | Jefferies | Buy |
| 2021-09-10 | Iniziato | SVB Leerink | Outperform |
| 2021-07-22 | Iniziato | Guggenheim | Buy |
| 2020-02-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-08-01 | Ripresa | H.C. Wainwright | Buy |
| 2016-11-07 | Iniziato | Aegis Capital | Buy |
| 2016-03-08 | Downgrade | Jefferies | Buy → Hold |
| 2016-03-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2016-03-07 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-03-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-03-01 | Iniziato | H.C. Wainwright | Buy |
| 2015-08-11 | Reiterato | Brean Capital | Buy |
| 2015-08-11 | Reiterato | Oppenheimer | Outperform |
| 2015-08-11 | Reiterato | ROTH Capital | Buy |
| 2015-06-02 | Reiterato | WBB Securities | Strong Buy |
| 2014-11-17 | Reiterato | ROTH Capital | Buy |
| 2014-03-04 | Reiterato | Oppenheimer | Outperform |
| 2013-07-08 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-08 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-02-26 | Reiterato | Oppenheimer | Outperform |
| 2013-01-10 | Reiterato | Cantor Fitzgerald | Buy |
| 2012-10-02 | Reiterato | Oppenheimer | Outperform |
| 2012-09-14 | Reiterato | Cantor Fitzgerald | Buy |
Mostra tutto
Celldex Therapeutics Inc Borsa (CLDX) Ultime notizie
Can Celldex Therapeutics Inc. stock reach $100 price targetMarket Activity Recap & Free Daily Entry Point Trade Alerts - newser.com
Real time alert setup for Celldex Therapeutics Inc. performanceTrade Analysis Report & Real-Time Volume Surge Alerts - newser.com
What’s next for Celldex Therapeutics Inc. stock priceForecast Cut & Advanced Technical Analysis Signals - newser.com
Is it too late to sell Celldex Therapeutics Inc.2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Published on: 2025-10-26 01:33:16 - newser.com
Published on: 2025-10-26 01:22:51 - newser.com
Why analysts remain bullish on Celldex Therapeutics Inc. stock2025 Pullback Review & Verified Momentum Watchlists - newser.com
What momentum shifts mean for Celldex Therapeutics Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will Celldex Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Action & Verified Entry Point Detection - newser.com
Is Celldex Therapeutics Inc. stock a bargain at current levelsPortfolio Update Summary & Safe Capital Growth Tips - newser.com
Chart overlay techniques for tracking Celldex Therapeutics Inc.Weekly Investment Recap & Community Verified Trade Alerts - newser.com
How Celldex Therapeutics Inc. (TCE2) stock trades in high volatilityMarket Movers & Verified Technical Signals - newser.com
Published on: 2025-10-25 02:57:01 - newser.com
Published on: 2025-10-24 02:30:04 - newser.com
Celldex Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Published on: 2025-10-23 07:06:05 - newser.com
Celldex Therapeutics (CLDX): Evaluating Valuation After Barclays' Underweight Rating and Industry Concerns - Yahoo Finance
Celldex Therapeutics Receives Bullish Analyst Coverage Amid Pipeline Developments - AD HOC NEWS
Will Celldex Therapeutics Inc. (TCE2) stock hit Wall Street targetsJobs Report & High Return Trade Guides - newser.com
Celldex Therapeutics Inc Azioni (CLDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):